Microbix Announces Quality Products Distribution Agreement

Nachrichtenquelle: globenewswire
12.05.2020, 13:00  |  104   |   |   

Appointment of D.I.D. S.p.A. of Milan for Italy

MISSISSAUGA, Ontario, May 12, 2020 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix), an award-winning life sciences innovator and exporter, announces the appointment of Diagnostic International Distribution S.p.A. of Milan (D.I.D.) as distributor of its Quality Assessment Products (QAPs) for Italy.

Under an agreement between the parties, D.I.D. has been appointed as distributor of Microbix’s quality assessment products (QAPs) for Italy. As distributor, D.I.D. will provide marketing, inventorying, distribution, and logistical support for use of Microbix’s QAPs by Italian clinical laboratories. At present, there are four dozen such QAPs across the PROCEEDx, REDxFLOQ, and REDx Controls tradenames – to support whole-process accuracy of tests for bacterial and viral diseases by emulating patient samples while being consistent, non-infectious, stable, and cross-instrument compatible. 

Based in Milan, D.I.D. is an Italian owned and operated life sciences distribution company that provides clinical laboratories with access to a wide range of products relating to immunological and molecular infectious disease testing. D.I.D. services approximately 1,000 customers throughout Italy and acts as a local representative for multiple leading test and reagent suppliers, including for Bio-Rad Laboratories, COPAN Italia, ELITechGroup, and Quidel, among others.

Microbix COVID-19 controls products are available in liquid format as well as on COPAN FLOQSwabs, which are especially familiar to Italian clinical laboratories. Additionally, Italy is one of the western countries that has largely converted cervical cancer screening programs to molecular HPV testing, making Microbix’s exceptional line of HPV test controls a great addition to D.I.D’s product portfolio.

Phil Casselli, SVP Business Development of Microbix, stated, “Italy’s northern region has been very hard hit by the coronavirus, so it is important to provide our COVID-19 controls to help its testing programs. We’re therefore honored to have D.I.D., a highly-respected company in the Italian community for many decades, representing our QAPs line of products. With the D.I.D. head office in Milan, and the leading global provider of patient sample collection swabs and media, COPAN Italia, less than an hour away, Microbix has the perfect partners to support provision of these important products to Italian testing labs.”

Seite 1 von 3
Microbix Biosystems Aktie jetzt ab 0€ handeln - auf Smartbroker.de



Diesen Artikel teilen
Mehr zum Thema
Klicken Sie auf eines der Themen und seien Sie stets dazu informiert. Mehr Informationen hier.
COVID-19CapCapitalCOP


0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel

Diskussionen zu den Werten

ZeitTitel
07.05.20